Nanjing Hicin Pharmaceutical News

Nanjing Hicin Pharmaceutical: Announcement of the Supervisory Board's resolution.

Aug 23 00:00

Nanjing Hicin Pharmaceutical: Summary of Non-Operating Fund Occupancy and Other Related Fund Transactions for January-June 2024.

Aug 23 00:00

Nanjing Hicin Pharmaceutical: Half-year report for the year 2024.

Aug 23 00:00

Nanjing Hicin Pharmaceutical: Summary of Half-Year Report in 2024.

Aug 23 00:00

Nanjing Hicin Pharmaceutical: Board of directors resolution announcement.

Aug 23 00:00

Nanjing Hicin Pharmaceutical: Announcement on the expiration and implementation of the plan for shareholding reduction by shareholders holding more than 5% of shares.

Aug 19 19:56

Nanjing Hicin Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.

Aug 16 16:20

Nanjing Hicin Pharmaceutical: Announcement regarding the change of company name and operation scope of a wholly-owned subsidiary.

Aug 15 16:46

Nanjing Hicin Pharmaceutical: Announcement on the Progress of Providing Guarantees to Wholly-owned Subsidiaries.

Aug 5 15:44

Nanjing Hicin Pharmaceutical: Announcement Regarding the Resignation and Appointment of Deputy General Managers.

Jul 29 15:42

Nanjing Hicin Pharmaceutical: Announcement of the resolutions of the 14th meeting of the 4th board of directors.

Jul 29 15:42

Nanjing Hicin Pharmaceutical: Announcement of shareholding reduction by shareholders who hold more than 5% of shares to less than 5% and notification of equity changes.

Jul 3 19:22

Nanjing Hicin Pharmaceutical: Simplified Equity Change Report

Jul 3 19:20

Nanjing Hicin Pharmaceutical: Announcement Regarding Company's Receipt of Approval Notice for Listing Application of Active Pharmaceutical Ingredient

Jun 17 16:28

Nanjing Hicin Pharmaceutical: Announcement on the pharmaceutical registration approval of propofol and tenofovir disoproxil fumarate tablets of the company.

Jun 12 16:28

Nanjing Hicin Pharmaceutical: Announcement of the implementation of equity distribution in 2023.

Jun 12 00:00

Nanjing Hicin Pharmaceutical: Legal Opinion of Jiangsu Century Tongren Law Firm on the Company's 2023 Annual General Meeting of Shareholders

May 15 17:22

Nanjing Hicin Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 15 17:22

Nanjing Hicin Pharmaceutical: 2023 Online Results Briefing and Investor Relations Activity Record Form 20240507

May 7 18:22

Haichen Pharmaceutical: Announcement on renewing the 2024 Audit Institution

Apr 25 00:00